Department of Internal Medicine, Division of Genetic Epidemiology, Department of Pathology, University of Utah, Salt Lake City, UT, USA.
Bioinformatics. 2010 Nov 1;26(21):2684-8. doi: 10.1093/bioinformatics/btq528. Epub 2010 Sep 27.
Targeted 'deep' sequencing of specific genes or regions is of great interest in clinical cancer diagnostics where some sequence variants, particularly translocations and indels, have known prognostic or diagnostic significance. In this setting, it is unnecessary to sequence an entire genome, and target capture methods can be applied to limit sequencing to important regions, thereby reducing costs and the time required to complete testing. Existing 'next-gen' sequencing analysis packages are optimized for efficiency in whole-genome studies and are unable to benefit from the particular structure of targeted sequence data.
We developed SLOPE to detect structural variants from targeted short-DNA reads. We use both real and simulated data to demonstrate SLOPE's ability to rapidly detect insertion/deletion events of various sizes as well as translocations and viral integration sites with high sensitivity and low false discovery rate.
Binary code available at http://www-genepi.med.utah.edu/suppl/SLOPE/index.html
在临床癌症诊断中,针对特定基因或区域的靶向“深度”测序非常有意义,因为某些序列变体(尤其是易位和插入缺失)具有已知的预后或诊断意义。在这种情况下,没有必要对整个基因组进行测序,并且可以应用目标捕获方法将测序限制在重要区域,从而降低成本并缩短测试完成所需的时间。现有的“下一代”测序分析软件包针对全基因组研究的效率进行了优化,无法从靶向序列数据的特定结构中受益。
我们开发了 SLOPE 来检测靶向短 DNA 读取的结构变体。我们使用真实和模拟数据来证明 SLOPE 能够快速检测各种大小的插入/缺失事件以及具有高灵敏度和低假阳性率的易位和病毒整合位点的能力。
二进制代码可在 http://www-genepi.med.utah.edu/suppl/SLOPE/index.html 获得。